Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Brexit Effect: A Blow To UK Life Science Leadership

This article was originally published in Scrip

Executive Summary

The debate over the UK's membership of the European Union is heating up, with both pro-and anti-EU groups having launched their respective campaigns in advance of the EU referendum, which is widely expected to take place in 2016. In the latest in our series on the effects of a "Brexit" in the life sciences area, Claire Skentelbery looks at the potential consequences for the UK research base, life science start-ups and the country's ability to lead European industry-academia collaborations.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts